ALPHA TRIBE

Tilaknagar Industries LimitedInvestor Meet, 11-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

11-02-2025 | 06:57 pm

1. Financial Performance: Tilaknagar Industries reported revenues of ₹340 crore for Q3 FY25, with a volume growth of 2.3%. However, excluding the impact of the new route-to-market (RTM) in Andhra Pradesh, primary volumes increased by 10%. EBITDA grew by 17% year-over-year, reaching ₹60 crore, resulting in an EBITDA margin of 17.7%. PAT saw a significant 23% rise to ₹54 crore, up from ₹44 crore the previous year. The quarterly NSR per case was ₹1,161, affected by pricing adjustments in Andhra Pradesh.

2. Future Outlook and Growth Drivers: Management remains optimistic, forecasting continued strong growth, bolstered by a 14% YoY volume uptick in January 2025. The focus will be on enhancing premiumization and sustaining momentum across key southern states, especially given the recoveries observed in Andhra.

3. Order Book and Operational Updates: The company's presence in southern markets demonstrated robust growth, particularly in Karnataka (+20% YoY) and other states. Management announced plans to invest ₹35-50 crore to expand production capacity at their Andhra unit, potentially increasing capacity from 6 lakh cases to 36 lakh cases.

4. Analyst Q&A Insights (Detailed):

- Revenue and Profitability: Analysts probed the sustainability of improved margins after reduced sales and distribution (S&D) expenses. Management conveyed that levels of S&D are expected to remain stable going forward, but indicated future increments in marketing spend could moderate margins.

- Market Position and Competitive Landscape: Analysts questioned the potential impact of competition in Andhra. Management reassured that brand strength and market share have been retained, and they expect continued volume recovery.

- Operational Challenges or Risks: Discussions centered on raw material pricing pressures, particularly ENA. Management anticipated stability in costs, reassuring analysts they don't foresee significant inflation.

- Capex and Capital Allocation: There was focused dialogue on utilizing cash reserves; management expressed openness to both organic growth and potential acquisitions to maximize shareholder value.

- Strategic Priorities and Long-Term Vision: Management highlighted a strategic pivot towards brand and market expansion emphasizing premium products.

5. Market or Regulatory Updates: Notable shifts in regulatory landscapes across southern India could foster a more favorable operational environment, similar to trends observed in UP.

6. Strategic Focus Areas: There is a clear emphasis on premiumization, market expansion, and innovation. Management's discussion reinforced their intention to enhance brand positioning within the Indian AlcoBev sector, aligning with new consumption trends.

7. Investor Insight: The robust growth trajectory, improved financial metrics, and strategic initiatives position the company favorably in the market. The sustained focus on brand equity and innovation supports a 'buy' stance, with attention on ongoing operational and market dynamics.

No comments yet. Be the first to comment!

All announcements from Tilaknagar Industries Limited